Baltimore, MA (March 8, 2020)—ACD/Labs and Nanalysis Scientific Corp. are pleased to announce that they have entered into a collaborative arrangement that will supply Nanalysis 60 and 100 MHz benchtop NMR spectrometer purchasers with ACD/Spectrus Processor software for data processing and analysis. The announcement was made at the 61st Experimental Nuclear Magnetic Resonance Conference (ENC) that brings spectroscopists from all over the world together to discuss innovations and applications of Nuclear Magnetic Resonance (NMR) spectroscopy.
Under the terms of the agreement, Nanalysis will bundle a one-year subscription of ACD/Spectrus Processor at no cost to academics, and for an incremental fee to industry. ACD/Labs’ industry-standard software that predicts spectra from structure (ACD/Labs NMR Predictors) and popular advanced processing, interpretation, and databasing application (ACD/NMR Workbook Suite) will also be available to Nanalysis customers.
Dr. Susanne Riegel, Director of Marketing and Product Manager said, “ACD/Labs’ powerful NMR processing and analysis software packages are the perfect accompaniment to our compact NMR devices. Working with ACD/Labs for manual or automated spectral analysis, to predict NMR spectra, to confirm structural assignments and build databases give our customers intuitive, powerful and flexible tools to simplify their analytic needs.”
“We’re very excited to work with Nanalysis and bring our tools to benchtop NMR users,” Dimitris Argyropoulos, NMR Business Manager at ACD/Labs, commented. “Benchtop instruments have made NMR spectroscopy more accessible to chemists all over the world. The ability to use ACD/Labs software to process and analyze their data will empower chemists with state-of-art tools that also enable them to store and manage their data effectively and produce publication-ready graphics and reports. Furthermore, ACD/Labs’ software offers the capability for chemists to process and analyze LC/MS, UV/Vis IR, and all other analytical data using the same software, regardless of data format.”
About Advanced Chemistry Development, Inc.
ACD/Labs is a leading provider of scientific software for R&D. We help our customers assemble digitized analytical, structural, and molecular information for effective decision-making, problem solving, and product lifecycle control. Our enterprise technologies enable automation of molecular characterization and facilitate chemically intelligent knowledge management.
ACD/Labs provides worldwide sales and support, and brings 25 years of experience and success helping organizations innovate and create efficiencies in their workflows. For more information, please visit www.acdlabs.com. Follow us on Twitter @ACDLabs.
About Nanalysis Scientific Corp. (TSXV:NSCI, FRA:1N1)
Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol ‘NSCI’. The company’s business is what we term “MRI for industry”: it develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first fully featured portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens, and the company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it will begin selling a 100MHz device in early 2020. The Company’s new device will be the most powerful non-cryogen, permanent magnet NMR device ever brought to market.
Nanalysis devices are used by chemical professionals in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, and more) as well as numerous government and university research labs around the world. The company continues to exploit new global market opportunities independently and with partners.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipate”, “continue”, “estimate”, “expect”, “may”, “would” occur. These statements are only predictions of what we believe might happen. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.